Mar v. Abbott Laboratories
Plaintiff: Mar and Ericka Mar
Defendant: Abbott Laboratories
Case Number: ILN/1:22-CV-00232
Filed: January 14, 2022
Court: Judicial Panel on Multidistrict Litigation
Presiding Judge: Marvin E Aspen
Referring Judge: Charles R Norgle
Nature of Suit: Other
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on March 14, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
March 14, 2022 Filing 17 SUPPLEMENTAL NOTICE OF HEARING SESSION re: pldg. (15 in CAC/2:21-cv-09932, 11 in CAC/5:21-cv-00481, 11 in CAC/5:21-cv-02145, 15 in CAC/5:21-cv-02146, 11 in CT/3:20-cv-01626, 10 in DC/1:20-cv-02537, 15 in FLM/6:21-cv-00502, 15 in FLN/1:21-cv-00201, 12 in ILN/1:22-cv-00071, 10 in ILN/1:22-cv-00192, 10 in ILN/1:22-cv-00197, 10 in ILN/1:22-cv-00203, 10 in ILN/1:22-cv-00204, 10 in ILN/1:22-cv-00232, 10 in ILN/1:22-cv-00239, 14 in LAM/3:21-cv-00687, #57 in MDL No. 3026) Signed by Clerk of the Panel John W. Nichols on 3/14/2022. Associated Cases: MDL No. 3026 et al. (RH)
March 7, 2022 Filing 16 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (10 in DC/1:20-cv-02537, 10 in ILN/1:22-cv-00192, 10 in ILN/1:22-cv-00197, 10 in ILN/1:22-cv-00203, 10 in ILN/1:22-cv-00204, 10 in ILN/1:22-cv-00232, #57 in MDL No. 3026), (9 in DC/1:20-cv-02537, 9 in ILN/1:22-cv-00192, 9 in ILN/1:22-cv-00197, 9 in ILN/1:22-cv-00203, 9 in ILN/1:22-cv-00204, 9 in ILN/1:22-cv-00232, #44 in MDL No. 3026) Filed by Stephen M. Reck on behalf of Plaintiffs Ericka Mar, #et al.Anthony Rinehart, Jessica Rinehart, Remington Rinehart, Dorothy Taylor, Dorothy Taylor, Lonnie Taylor, Jr, Jessica Gshwend, Emma Hodges, Justin Hodges, Ashton Brown, Megan Stuper, ASHIA GEORGE #[Suppress List] (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 3026, DC/1:20-cv-02537, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv -00204, ILN/1:22-cv-00232 (Reck, Stephen)
February 28, 2022 Filing 15 NOTICE OF PRESENTATION OF ORAL ARGUMENT (AMENDED) re: pldg. ( 59 in MDL No. 3026) Stephanie E Parker replaces Meir Feder and is now designated to present oral argument on behalf of Defendants Abbott Laboratories, Inc., #et al.Abbott Laboratories, #[Suppress List] (Attachments: #1 Other Short Case Captions) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILN/1:22-cv-00561, ILS/3:21-cv-01703, LAM/3:21-cv-00687, MOE/4:22-cv-00144, MOW/4:22-cv-00032, MOW/4:22-cv-00033, NV/2:22-cv-00273, TXS/4:22-cv-00230 (Parker, Stephanie) Modified on 3/1/2022 (RH). DELETED DUPLICATE PARTIES NAMES
February 28, 2022 Filing 14 SEE CORRECTED PLDG. 74 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( #16 in MDL No. 3026, 24 in MDL No. 3026, 35 in MDL No. 3026, 38 in MDL No. 3026, 58 in MDL No. 3026, 69 in MDL No. 3026, 71 in MDL No. 3026) Filed by Meir Feder on behalf of Defendants Abbott Laboratories, Inc., #et al.Abbott Laboratories #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILN/1:22-cv-00561, LAM/3:21-cv-00687, MOE/4:22-cv-00144, MOW/4:22-cv-00032, MOW/4:22-cv-00033, NV/2:22-cv-00273, TXS/4:22-cv-00230 (Feder, Meir) ADDED MDL LINKS & DELETED DUPLICATE ENTRIES Modified on 3/1/2022 (CMD). Modified on 3/2/2022 (CMD).
February 17, 2022 Filing 13 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #1 in MDL No. 3026) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Pa nel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel John W. Nichols on 2/17/2022. Associated Cases: MDL No. 3026 et al. (CMD)
February 16, 2022 Filing 12 REPLY TO RESPONSE TO MOTION FOR TRANSFER re: pldg. ( 1 in MDL No. 3026, 40 in MDL No. 3026, 41 in MDL No. 3026, 42 in MDL No. 3026, 44 in MDL No. 3026, 45 in MDL No. 3026, 46 in MDL No. 3026, 47 in MDL No. 3026, 48 in MDL No. 3026, 52 in MDL No. 3026, 53 in MDL No. 3026, 56 in MDL No. 3026, 60 in MDL No. 3026) Filed by Defendants Abbott Laboratories, Inc., #et al.Abbott Laboratories #[Suppress List] (Attachments: #1 Exhibit A - National Judicial Caseload Profile Statistics, #2 Exhibit B - Koeth Plaintiff's Letter Response, #3 Exhibit C - Lincoln Stay Order Notice of Electronic Filing, #4 Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:21-cv-06234, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILN/1:22-cv-00363, ILN/1:22-cv-00561, LAM/3:21-cv-00687, MOE/4:22-cv-00144, MOW/4:22-cv-00032, MOW/4:22-cv-00033, NV/2:22-cv-00273, TXS/4:22-cv-00230 (Feder, Meir) ADDED MDL LINKS Modified on 2/17/2022 (CMD).
February 15, 2022 Filing 11 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (15 in CAC/2:21-cv-09932, 11 in CAC/5:21-cv-00481, 11 in CAC/5:21-cv-02145, 15 in CAC/5:21-cv-02146, 11 in CT/3:20-cv-01626, 10 in DC/1:20-cv-02537, 15 in FLM/6:21-cv-00502, 15 in FLN/1:21-cv-00201, 12 in ILN/1:22-cv-00071, 10 in ILN/1:22-cv-00192, 10 in ILN/1:22-cv-00197, 10 in ILN/1:22-cv-00203, 10 in ILN/1:22-cv-00204, 10 in ILN/1:22-cv-00232, 10 in ILN/1:22-cv-00239, 14 in LAM/3:21-cv-00687, 57 in MDL No. 3026), ( 1 in MDL No. 3026) Filed by Meir Feder on behalf of Defendants Abbott Laboratories, Inc., #et al.Abbott Laboratories, #[Suppress List] (Attachments: #1 Other Short Case Captions) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILN/1:22-cv-00561, LAM/3:21-cv-00687, MOE/4:22-cv-00144, MOW/4:22-cv-00032, MOW/4:22-cv-00033, NV/2:22-cv-00273, TXS/4:22-cv-00230 (Feder, Meir) Modified on 2/16/2022 (RH). DELETED DUPLICATE PARTIES NAMES
February 14, 2022 Opinion or Order Filing 10 HEARING ORDER re: pldg. ( #1 in MDL No. 3026) - SECTION A (DESIGNATED FOR ORAL ARGUMENT) PANEL HEARING set for 3/31/2022 in New Orleans, Lou isiana. Notices of Presentation or Waiver of Oral Argument due on or before 3/7/2022.#Notice of Presentation or Waiver of Oral Argument form (JPML form 9) can be downloaded from our website.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 2/14/2022. (Attachments: #1 Courthouse Advisory) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-0 0502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, LAM/3:21-cv-00687 (RH)
February 9, 2022 Filing 9 RESPONSE (JOINDER) -- (re: pldg. ( 40 in MDL No. 3026), ( 1 in MDL No. 3026) ) Filed by Plaintiffs Ericka Mar, #et al.Anthony Rinehart, Jessica Rinehart, Remington Rinehart, Dorothy Taylor, Lonnie Taylor, Jr, Jessica Gshwend, Emma Hodges, Justin Hodges, Ashton Brown, Megan Stuper, ASHIA GEORGE #[Suppress List] (Attachments: #1 Oral Argument Statement, #2 Proof of Service) Associated Cases: MDL No. 3026, DC/1:20-cv-02537, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232 (Reck, Stephen) DELETED DUPLICATE PARTY NAME Modified on 2/9/2022 (CMD).
January 27, 2022 Filing 8 ERRATA - to (5 in CAC/2:21-cv-09932, 5 in CAC/5:21-cv-00481, 5 in CAC/5:21-cv-02145, 5 in CAC/5:21-cv-02146, 7 in CT/3:20-cv-01626, 6 in DC/1:20-cv-02537, 7 in FLM/6:21-cv-00502, 7 in FLN/1:21-cv-00201, 7 in ILN/1:22-cv-00071, 5 in ILN/1:22-cv-00192, 5 in ILN/1:22-cv-00197, 5 in ILN/1:22-cv-00203, 5 in ILN/1:22-cv-00204, 6 in ILN/1:22-cv-00232, 5 in ILN/1:22-cv-00239, 5 in ILS/3:21-cv-01703, 6 in LAM/3:21-cv-00687, 19 in MDL No. 3026, 1 in MOW/4:22-cv-00032, 1 in MOW/4:22-cv-00033) - Filed by Defendants Abbott Laboratories, Inc., Abbott Laboratories. (Attachments: #1 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687, MOW/4:22-cv-00032, MOW/4:22-cv-00033 (Feder, Meir) DELETED DUPLICATE PARTY NAMES Modified on 1/28/2022 (CMD).
January 27, 2022 Filing 7 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 3026) -- Identifying Corporate Parent Abbott Laboratories for Abbott Laboratories, Inc.. (Attachments: #1 Exhibit Schedule of Actions, #2 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687, MOW/4:22-cv-00032, MOW/4:22-cv-00033 (Feder, Meir) DELETED DUPLICATE PARTY NAME Modified on 1/27/2022 (CMD).
January 27, 2022 Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 3026) -- Identifying Corporate Parent No Parent Corp. for Abbott Laboratories. (Attachments: #1 Exhibit Schedule of Actions, #2 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687, MOW/4:22-cv-00032, MOW/4:22-cv-00033 (Feder, Meir) EDITED CORP. PARENT & DELETED DUPLICATE PARTY NAME Modified on 1/27/2022 (CMD).
January 26, 2022 Filing 5 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 3026) Filed by Stephen M. Reck on behalf of Plaintiffs Ericka Mar, ASHIA GEORGE (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3026, DC/1:20-cv-02537, ILN/1:22-cv-00232 (Reck, Stephen)
January 24, 2022 Filing 4 NOTICE OF APPEARANCE (CORRECTED) re: pldg.( 1 in MDL No. 3026, 13 in MDL No. 3026) Filed by Meir Feder on behalf of Defendants Abbott Laboratories, Inc., #et al.Abbott Laboratories. #[Suppress List] (Attachments: #1 Exhibit Schedule of Actions, #2 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687 (Feder, Meir) EDITED EVENT TYPE, ADDED MDL LINK 13 AND DELETED DUPLICATE PARTY NAMES Modified on 1/25/2022 (CMD).
January 24, 2022 Filing 3 SEE CORRECTED PLDG. 14 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 3026) Filed by Meir Feder on behalf of Defendants Abbott Laboratories, Inc., #et al.Abbott Laboratories. #[Suppress List] (Attachments: #1 Exhibit Schedule of Actions, #2 Exhibit Proof of Service) Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687 (Feder, Meir) Modified on 1/25/2022 (CMD).
January 19, 2022 Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 3026), ( #2 in MDL No. 3026) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 2/2/2022. Corporate Disclosure Statements due on or before 2/2/2022. Responses due on or before 2/9/2022. Reply, if any, due on or before 2/16/2022. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 1/19/2022. Associated Cases: MDL No. 3026, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21-cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687 (TF)
January 19, 2022 Filing 1 MDL Number 3026 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 62) Associated Cases: Pending No. 62, CAC/2:21-cv-09932, CAC/5:21-cv-00481, CAC/5:21- cv-02145, CAC/5:21-cv-02146, CT/3:20-cv-01626, DC/1:20-cv-02537, FLM/6:21-cv-00502, FLN/1:21-cv-00201, ILN/1:22-cv-00071, ILN/1:22-cv-00192, ILN/1:22-cv-00197, ILN/1:22-cv-00203, ILN/1:22-cv-00204, ILN/1:22-cv-00232, ILN/1:22-cv-00239, ILS/3:21-cv-01703, LAM/3:21-cv-00687 (TF)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Judicial Panel on Multidistrict Litigation's Electronic Court Filings (ECF) System

Search for this case: Mar v. Abbott Laboratories
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Mar
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Ericka Mar
Represented By: Elizabeth A. Kaveny
Represented By: Jose Rojas
Represented By: Stephen M. Reck
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Abbott Laboratories
Represented By: Bridget K O'Connor
Represented By: Bryce Allen Cooper
Represented By: Linda T Coberly
Represented By: Meir Feder
Represented By: Stephanie E Parker
Represented By: Stephen Victor D'Amore
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?